drugset / Trial / NCT00320424
Hip Fracture Study of GSK576428 (Fondaparinux Sodium)
Non-randomizedSingle-groupOpen-labelPrevention
Summary
This study is requested by PMDA to confirm the efficacy and the safety for HFS.
Timeline
- Start
- 2006-02-16
- Primary completion
- 2006-10-26
- Completion
- 2006-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fondaparinux | Other / unclassified | — | — |